Role of inflammatory cells and adenosine in lung ischemia reoxygenation injury using a model of lung donation after cardiac death

References

• Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, et al. International Society of H, Lung T. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transpl. 2012;31:1073–1086.
   PubMed Web of Science ®Google Scholar
• De Vleeschauwer S, Van Raemdonck D, Vanaudenaerde B, Vos R, Meers C, Wauters S, et al. Early outcome after lung transplantation from non-heart-beating donors is comparable to heart-beating donors. J Heart Lung Transpl. 2009;28:380–387.
   PubMed Web of Science ®Google Scholar
• Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transpl. 2007;26:681–686.
   PubMed Web of Science ®Google Scholar
• de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J of Resp. Crit. Care Med. 2003;167:490–511.
   PubMed Web of Science ®Google Scholar
• Fiser SM, Tribble CG, Long SM, Kaza AK, Cope JT, Laubach VE, et al. Lung transplant reperfusion injury involves pulmonary macrophages and circulating leukocytes in a biphasic response. J Thorac Cardiovasc Surg 2001;121:1069–1075.
   PubMed Web of Science ®Google Scholar
• de Perrot M, Young K, Imai Y, Liu M, Waddell TK, Fischer S, Zhang L, Keshavjee S. Recipient t cells mediate reperfusion injury after lung transplantation in the rat. J Immunol 2003;171:4995–5002.
   PubMed Web of Science ®Google Scholar
• Fernandez LG, Sharma AK, LaPar DJ, Kron IL, Laubach VE. Adenosine a1 receptor activation attenuates lung ischemia-reperfusion injury. J Thorac Cardiovasc Surg 2013;145:1654–1659.
   PubMed Web of Science ®Google Scholar
• Bion A, Fal M, Gouriou F, Le Prieur E, Dionnet F, Morin JP. Biphasic culture of rat lung slices for pharmacotoxicological evaluation of complex atmospheres. Cell Biol Toxicol 2002;18:301–314.
   PubMed Web of Science ®Google Scholar
• Morin JP, Baste JM, Gay A, Crochemore C, Corbiere C, Monteil C. Precision cut lung slices as an efficient tool for in vitro lung physio-pharmacotoxicology studies. Xenobiotica 2013;43:63–72.
   PubMed Web of Science ®Google Scholar
• Sroka J, Kordecka A, Wlosiak P, Madeja Z, Korohoda W. Separation methods for isolation of human polymorphonuclear leukocytes affect their motile activity. Eur J Cell Biol 2009;88:531–539.
   PubMed Web of Science ®Google Scholar
• Liberati TA, Randle MR, Toth LA. In vitro lung slices: A powerful approach for assessment of lung pathophysiology. Expert Review of Molecular Diagnostics 2010;10:501–508.
   PubMed Web of Science ®Google Scholar
• Sewald K, Braun A. Assessment of immunotoxicity using precision-cut tissue slices. Xenobiotica. 2013;43:84–97.
   PubMed Web of Science ®Google Scholar
• Bull DA, Connors RC, Reid BB, Albanil A, Stringham JC, Karwande SV. Improved biochemical preservation of lung slices during cold storage. J. Surgical Res. 2000;90:144–148.
   PubMed Web of Science ®Google Scholar
• Henjakovic M, Sewald K, Switalla S, Kaiser D, Muller M, Veres TZ, et al. Ex vivo testing of immune responses in precision-cut lung slices. Toxicol. Appl. Pharmaco. 2008;231:68–76.
   PubMed Web of Science ®Google Scholar
• Henjakovic M, Martin C, Hoymann HG, Sewald K, Ressmeyer AR, Dassow C, et al. Ex vivo lung function measurements in precision-cut lung slices (pcls) from chemical allergen-sensitized mice represent a suitable alternative to in vivo studies. Toxicol. Sci, 2008;106:444–453.
   PubMed Web of Science ®Google Scholar
• Switalla S, Lauenstein L, Prenzler F, Knothe S, Forster C, Fieguth HG, et al. Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices. Toxicol. Appl. Pharmacol. 2010.
   Web of Science ®Google Scholar
• Ross SD, Tribble CG, Gaughen JR, Shockey KS, Parrino PE, Kron IL. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation. Ann. Thorac. Surg. 1999;67:1428–1433; discussion 1434.
   PubMed Web of Science ®Google Scholar
• Eppinger MJ, Deeb GM, Bolling SF, Ward PA. Mediators of ischemia-reperfusion injury of rat lung. Am. J. Pathol. 1997;150:1773–1784.
   PubMed Web of Science ®Google Scholar
• Steimle CN, Guynn TP, Morganroth ML, Bolling SF, Carr K, Deeb GM. Neutrophils are not necessary for ischemia-reperfusion lung injury. Ann. Thoracic Surg. 1992;53:64–72; discussion 72–63.
   PubMed Web of Science ®Google Scholar
• Zhao M, Fernandez LG, Doctor A, Sharma AK, Zarbock A, Tribble CG, et al. Alveolar macrophage activation is a key initiation signal for acute lung ischemia-reperfusion injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2006;291:L1018–L1026.
   Google Scholar
• Maxey TS, Enelow RI, Gaston B, Kron IL, Laubach VE, Doctor A. Tumor necrosis factor-alpha from resident lung cells is a key initiating factor in pulmonary ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 2004;127:541–547.
   PubMed Web of Science ®Google Scholar
• Geudens N, Vanaudenaerde BM, Neyrinck AP, Van De Wauwer C, Vos R, Verleden GM, et al. The importance of lymphocytes in lung ischemia-reperfusion injury. Transplant. Proc. 2007;39:2659–2662.
   PubMed Web of Science ®Google Scholar
• Zaouali MA, Ben Abdennebi H, Padrissa-Altes S, Mahfoudh-Boussaid A, Rosello-Catafau J. Pharmacological strategies against cold ischemia reperfusion injury. Expert Opin. Phar. 2010;11:537–555.
   PubMed Web of Science ®Google Scholar
• Grenz A, Homann D, Eltzschig HK. Extracellular adenosine: A safety signal that dampens hypoxia-induced inflammation during ischemia. Antioxidants & Redox Signaling 2011;15:2221–2234.
   PubMed Web of Science ®Google Scholar
• Reece TB, Ellman PI, Maxey TS, Crosby IK, Warren PS, Chong TW, et al. Adenosine a2a receptor activation reduces inflammation and preserves pulmonary function in an in vivo model of lung transplantation. J. Thorac. Cardiovasc. Surg. 2005;129:1137–1143.
   PubMed Web of Science ®Google Scholar
• Sharma AK, Linden J, Kron IL, Laubach VE. Protection from pulmonary ischemia-reperfusion injury by adenosine a2a receptor activation. Resp. Res. 2009;10:58.
   PubMedGoogle Scholar
• Sharma AK, Laubach VE, Ramos SI, Zhao Y, Stukenborg G, Linden J, et al. Adenosine a2a receptor activation on cd4+ t lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury. J. Thorac. Cardiovasc. Surg. 2010;139:474–482.
   PubMed Web of Science ®Google Scholar
• Gazoni LM, Laubach VE, Mulloy DP, Bellizzi A, Unger EB, Linden J, et al. Additive protection against lung ischemia-reperfusion injury by adenosine a2a receptor activation before procurement and during reperfusion. J. Thorac. Cardiovasc. Surg. 2008;135:156–165.
   PubMed Web of Science ®Google Scholar